Project description
A novel optical approach for studying and treating the brain
Currently, optogenetics is employed to measure neuronal activity and study brain function. However, it requires genetically encoded proteins, limiting its translational applicability. The EU-funded NanoBRIGHT project is developing a novel technology based on the interaction of light with metallic nanostructures which will increase the range of physiological phenomena that can be controlled and monitored by light in vivo. This includes the modulation of the blood–brain barrier's permeability to allow pharmacological targeting of the brain, as well as the possibility to identify tumorigenic tissue without the need of a biopsy. The new approach will advance the treatment of pathological conditions including brain tumours, epilepsy and traumatic brain injuries.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
16163 Genova
Italy
See on map
Participants (4)
28006 Madrid
See on map
75794 Paris
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
75006 Paris
See on map
28029 Madrid
See on map